Literature DB >> 18221179

Oral immune regulation: a new mode of therapy against chronic viral infections.

Liran Levy1, Yaron Ilan.   

Abstract

Oral tolerance is a method to alter the immune response towards orally administered antigens. The use of oral tolerance as a method of therapy for various immune mediated processes, including infectious, inflammatory and neoplastic entities, has been the subject of much research in recent years. The therapeutic potential of modifying the immune response by oral ingestion of disease-associated antigens is gaining recognition, and is being assessed in diverse settings. Studies have shown that anti-viral immunity can be modulated by oral feeding of viral proteins in animal models, and recent data suggest that this can also be achieved in humans. Oral administration of HBV-envelope proteins to patients with chronic HBV infection has been shown to be beneficial, not only for alleviation of immune-mediated liver injury but also for enhancement of effective anti-viral immunity. Several patents described the use of oral administration of viral particles as a mean of altering the anti viral immune response. Natural killer T (NKT) lymphocytes, a subset of regulatory T lymphocytes, can induce pro-inflammatory or anti-inflammatory immune responses. This subset of cells appears to be crucial for induction of tolerance by several interventions, including oral tolerance. This review summarizes the data on induction of tolerance towards viruses, and on the role of NKT regulatory cells in this setting. Several patents described the use of this method a treatment mode for viral infections and the use of NKT cells in this settings.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18221179     DOI: 10.2174/157489107782497353

Source DB:  PubMed          Journal:  Recent Pat Antiinfect Drug Discov        ISSN: 1574-891X


  2 in total

Review 1.  Antiseptic use in the neonatal intensive care unit - a dilemma in clinical practice: An evidence based review.

Authors:  Sundar Sathiyamurthy; Jayanta Banerjee; Sunit V Godambe
Journal:  World J Clin Pediatr       Date:  2016-05-08

2.  Oral Administration of Heat-Killed Mycobacterium manresensis Delays Progression toward Active Tuberculosis in C3HeB/FeJ Mice.

Authors:  Paula Cardona; Elena Marzo-Escartín; Gustavo Tapia; Jorge Díaz; Vanessa García; Ismael Varela; Cristina Vilaplana; Pere-Joan Cardona
Journal:  Front Microbiol       Date:  2016-01-05       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.